Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benshang Li

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Journal of Translational Medicine|March 23, 2023
Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapyWenjie Li, Lixia Ding, Wenhua Shi, et al.
Haematologica|March 19, 2026
CD19/CD22-targeted CAR T cells in autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantationLiu Yang, Xinyu Wan, Chengjuan Luo, et al.
Cancer Medicine|September 28, 2022
Association between body mass index at diagnosis and outcomes in Chinese children with newly diagnosed acute lymphoblastic leukemiaWenting Hu, Yin Ting Cheung, Yanjing Tang, et al.
Frontiers in Pediatrics|January 28, 2025
Impact of corticosteroids on the efficacy of CD19/22 CAR-T cell therapy in pediatric patients with B-ALL: a single-center studyJing Yang, Jing Zhang, Xinyu Wan, et al.
Haematologica|May 22, 2025
Durable remission achieved in pediatric patients with <i>TCF3-HLF</i>-positive relapsed / refractory B-cell acute lymphoblastic leukemia by dual CD19 and CD22-targeted chimeric antigen receptor T-cell therapyXinyu Wan, Tianyi Wang, Jing Yang, et al.
Frontiers in Medicine|April 27, 2026
Long-term outcomes of co-administration of CD19 and CD22 CAR-T cell therapy in pediatric patients with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemiaZichao Zhou, Tianyi Wang, Wenhua Shi, et al.
Nature Communications|February 10, 2017
Small genomic insertions form enhancers that misregulate oncogenesBrian J Abraham, Denes Hnisz, Abraham S Weintraub, et al.
Genome Biology|March 15, 2019
Analysis of error profiles in deep next-generation sequencing dataXiaotu Ma, Ying Shao, Liqing Tian, et al.
Nature Communications|June 2, 2017
Corrigendum: Small genomic insertions form enhancers that misregulate oncogenesBrian J Abraham, Denes Hnisz, Abraham S Weintraub, et al.
Nature Communications|October 25, 2023
Chromatin accessibility landscape of relapsed pediatric B-lineage acute lymphoblastic leukemiaHan Wang, Huiying Sun, Bilin Liang, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Translational Medicine|March 23, 2023
Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapyWenjie Li, Lixia Ding, Wenhua Shi, et al.
Haematologica|March 19, 2026
CD19/CD22-targeted CAR T cells in autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantationLiu Yang, Xinyu Wan, Chengjuan Luo, et al.
Cancer Medicine|September 28, 2022
Association between body mass index at diagnosis and outcomes in Chinese children with newly diagnosed acute lymphoblastic leukemiaWenting Hu, Yin Ting Cheung, Yanjing Tang, et al.
Frontiers in Pediatrics|January 28, 2025
Impact of corticosteroids on the efficacy of CD19/22 CAR-T cell therapy in pediatric patients with B-ALL: a single-center studyJing Yang, Jing Zhang, Xinyu Wan, et al.
Haematologica|May 22, 2025
Durable remission achieved in pediatric patients with <i>TCF3-HLF</i>-positive relapsed / refractory B-cell acute lymphoblastic leukemia by dual CD19 and CD22-targeted chimeric antigen receptor T-cell therapyXinyu Wan, Tianyi Wang, Jing Yang, et al.
Frontiers in Medicine|April 27, 2026
Long-term outcomes of co-administration of CD19 and CD22 CAR-T cell therapy in pediatric patients with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemiaZichao Zhou, Tianyi Wang, Wenhua Shi, et al.
Nature Communications|February 10, 2017
Small genomic insertions form enhancers that misregulate oncogenesBrian J Abraham, Denes Hnisz, Abraham S Weintraub, et al.
Genome Biology|March 15, 2019
Analysis of error profiles in deep next-generation sequencing dataXiaotu Ma, Ying Shao, Liqing Tian, et al.
Nature Communications|June 2, 2017
Corrigendum: Small genomic insertions form enhancers that misregulate oncogenesBrian J Abraham, Denes Hnisz, Abraham S Weintraub, et al.
Nature Communications|October 25, 2023
Chromatin accessibility landscape of relapsed pediatric B-lineage acute lymphoblastic leukemiaHan Wang, Huiying Sun, Bilin Liang, et al.
Pageof 5